Menu
GeneBe

rs11564720

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000207.3(INS):c.63A>G(p.Pro21=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,612,630 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0050 ( 6 hom., cov: 35)
Exomes 𝑓: 0.00070 ( 5 hom. )

Consequence

INS
NM_000207.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: -2.88
Variant links:
Genes affected
INS (HGNC:6081): (insulin) This gene encodes insulin, a peptide hormone that plays a vital role in the regulation of carbohydrate and lipid metabolism. After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified, including insulin-dependent diabetes mellitus, permanent neonatal diabetes diabetes mellitus, maturity-onset diabetes of the young type 10 and hyperproinsulinemia. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.09).
BP6
Variant 11-2160909-T-C is Benign according to our data. Variant chr11-2160909-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 255533.We mark this variant Likely_benign, oryginal submissions are: {Benign=3, Likely_benign=1, Uncertain_significance=1}. Variant chr11-2160909-T-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00504 (767/152308) while in subpopulation AFR AF= 0.0171 (709/41572). AF 95% confidence interval is 0.016. There are 6 homozygotes in gnomad4. There are 350 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd at 766 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
INSNM_000207.3 linkuse as main transcriptc.63A>G p.Pro21= synonymous_variant 2/3 ENST00000381330.5
INS-IGF2NR_003512.4 linkuse as main transcriptn.122A>G non_coding_transcript_exon_variant 2/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
INSENST00000381330.5 linkuse as main transcriptc.63A>G p.Pro21= synonymous_variant 2/31 NM_000207.3 P1P01308-1

Frequencies

GnomAD3 genomes
AF:
0.00503
AC:
766
AN:
152190
Hom.:
6
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00527
GnomAD3 exomes
AF:
0.00148
AC:
366
AN:
247266
Hom.:
1
AF XY:
0.00123
AC XY:
166
AN XY:
134450
show subpopulations
Gnomad AFR exome
AF:
0.0178
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000245
Gnomad OTH exome
AF:
0.000823
GnomAD4 exome
AF:
0.000698
AC:
1019
AN:
1460322
Hom.:
5
Cov.:
88
AF XY:
0.000640
AC XY:
465
AN XY:
726482
show subpopulations
Gnomad4 AFR exome
AF:
0.0173
Gnomad4 AMR exome
AF:
0.00130
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.0000384
Gnomad4 NFE exome
AF:
0.000244
Gnomad4 OTH exome
AF:
0.00161
GnomAD4 genome
AF:
0.00504
AC:
767
AN:
152308
Hom.:
6
Cov.:
35
AF XY:
0.00470
AC XY:
350
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.0171
Gnomad4 AMR
AF:
0.00183
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000221
Gnomad4 OTH
AF:
0.00521
Alfa
AF:
0.00265
Hom.:
1
Bravo
AF:
0.00606
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJul 30, 2020- -
Benign, criteria provided, single submitterclinical testingInvitaeDec 02, 2023- -
Maturity-onset diabetes of the young type 10 Uncertain:1
Uncertain significance, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine Clinic-Potent mutations in the INS gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, mutations in this gene can cause beta cell destruction.However, more evidence is required to confer the association of this particular synonymous variant P21P/ rs11564720 with Maturity-onset diabetes of the young (MODY). -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 07, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.1
Cadd
Benign
0.011
Dann
Benign
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11564720; hg19: chr11-2182139; API